4-hydroxy-3,5-dimethoxycinnamate choline, sinapine, sinapine bisulphate, sinapine, monosulfate salt, sinapine, thiocyanate salt
Name | Sinapine | ||
PubChem CID | 5280385 | ||
Molecular Weight | 310.36g/mol | ||
Synonyms |
4-hydroxy-3,5-dimethoxycinnamate choline, sinapine, sinapine bisulphate, sinapine, monosulfate salt, sinapine, thiocyanate salt |
||
Formula | C₁₆H₂₄NO₅+ | ||
SMILES | C[N+](C)(C)CCOC(=O)C=CC1=CC(=C(C(=C1)OC)O)OC | ||
InChI | 1S/C16H23NO5/c1-17(2,3)8-9-22-15(18)7-6-12-10-13(20-4)16(19)14(11-12)21-5/h6-7,10-11H,8-9H2,1-5H3/p+1 | ||
InChIKey | HUJXHFRXWWGYQH-UHFFFAOYSA-O | ||
CAS Number | 18696-26-9 | ||
ChEBI ID | CHEBI:16353 | ||
Herb ID | HBIN044064 | ||
KEGG ID | C00933 | ||
Structure |
Download
2D
MOL
3D
MOL
|
Chineses Pinyin | BaiJieZi | ||
Use Part | Seed | ||
Habitat | LiaoNing, ShanXi, XinJiang, ShanDong, AnHui, SiChuan, YunNan | ||
Flavor | Pungent | ||
Meridian Tropism | Lung, Liver, Spleen, Stomach, Pericardium | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Brassicales
-->Family: Brassicaceae
-->Genus: Sinapis
-->Species: Sinapis alba
|
Chineses Pinyin | BaiJie | ||
Use Part | Seed | ||
Habitat | LiaoNing, ShanXi, XinJiang, ShanDong, AnHui, SiChuan, YunNan | ||
Flavor | Pungent | ||
Meridian Tropism | Lung | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Brassicales
-->Family: Brassicaceae
-->Genus: Sinapis
-->Species: Sinapis alba
|
Pair Name | Sinapine, Doxorubicin | |||
Partner Name | Doxorubicin | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Gene Regulation | Down-regulation | Expression | ABCB1 | hsa5243 |
Down-regulation | Expression | FOXP3 | hsa50943 | |
Up-regulation | Expression | IL17A | hsa3605 | |
In Vitro Model | MCF-7 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_0031 |
Result | Our findings indicated that sinapine played an important role in the downregulation of MDR1 expression through suppression of fibroblast growth factor receptor (FGFR)4/FRS2α-ERK1/2 mediated NF-κB activation in MCF-7/dox cancer cells. |